Abstract
Background: OSA is a common disorder with significant neuropsychiatric morbidity. Studies have shown a 20% prevalence of depression in OSA patients. Prevalence of anxiety disorders in OSA has not been well characterized.
Objective: The objective of this study was to examine the prevalence of depression and anxiety disorders in a cohort of patients with OSA, and evaluate the influence of gender and ethnicity.
Methodology: A retrospective study was carried out on consecutive patients referred for polysomnography at our tertiary care county hospital sleep center. Patients were administered the Hospital Anxiety and Depression Scale (HADS) in addition to routine sleep questionnaires. Scores of >10 were considered positive for both anxiety, and for depression respectively. Patients over age 18 years and AHI > 5 on the sleep study were included in the analysis.
Results: 51 patients meeting the inclusion criteria filled out a valid questionnaire. The prevalence of both anxiety, as well as depression, was very high (52.9 % and 39.2% respectively). There was a significantly higher prevalence of anxiety in females as compared to males. (62.5% vs 36.8% respectively; p < 0.05). African-American patients had higher rates of anxiety than Caucasians (66.7% vs 30.7%; p < 0.05). No gender or ethnic variance was seen in prevalence of depression.
Conclusions: Anxiety, as well as depression, are extremely prevalent in patients with OSA, and are significantly underappreciated. Our data suggest that both gender and ethnicity may influence the prevalence of anxiety in OSA.
Keywords: Anxiety, depression, ethnic variances, obstructive sleep apnea.
Current Respiratory Medicine Reviews
Title:Anxiety and Depression in Obstructive Sleep Apnea: Prevalence and Gender/Ethnic Variance
Volume: 9 Issue: 4
Author(s): Salim Surani, Shweta Rao, Saherish Surani, Bharat Guntupalli and Shyam Subramanian
Affiliation:
Keywords: Anxiety, depression, ethnic variances, obstructive sleep apnea.
Abstract: Background: OSA is a common disorder with significant neuropsychiatric morbidity. Studies have shown a 20% prevalence of depression in OSA patients. Prevalence of anxiety disorders in OSA has not been well characterized.
Objective: The objective of this study was to examine the prevalence of depression and anxiety disorders in a cohort of patients with OSA, and evaluate the influence of gender and ethnicity.
Methodology: A retrospective study was carried out on consecutive patients referred for polysomnography at our tertiary care county hospital sleep center. Patients were administered the Hospital Anxiety and Depression Scale (HADS) in addition to routine sleep questionnaires. Scores of >10 were considered positive for both anxiety, and for depression respectively. Patients over age 18 years and AHI > 5 on the sleep study were included in the analysis.
Results: 51 patients meeting the inclusion criteria filled out a valid questionnaire. The prevalence of both anxiety, as well as depression, was very high (52.9 % and 39.2% respectively). There was a significantly higher prevalence of anxiety in females as compared to males. (62.5% vs 36.8% respectively; p < 0.05). African-American patients had higher rates of anxiety than Caucasians (66.7% vs 30.7%; p < 0.05). No gender or ethnic variance was seen in prevalence of depression.
Conclusions: Anxiety, as well as depression, are extremely prevalent in patients with OSA, and are significantly underappreciated. Our data suggest that both gender and ethnicity may influence the prevalence of anxiety in OSA.
Export Options
About this article
Cite this article as:
Surani Salim, Rao Shweta, Surani Saherish, Guntupalli Bharat and Subramanian Shyam, Anxiety and Depression in Obstructive Sleep Apnea: Prevalence and Gender/Ethnic Variance, Current Respiratory Medicine Reviews 2013; 9 (4) . https://dx.doi.org/10.2174/1573398X09666131217002138
DOI https://dx.doi.org/10.2174/1573398X09666131217002138 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Polyphenols and Neuroprotection against Ischemia and Neurodegeneration
Mini-Reviews in Medicinal Chemistry Deregulation of PI3K/Akt/mTOR Signaling Pathways by Isoflavones and its Implication in Cancer Treatment
Anti-Cancer Agents in Medicinal Chemistry Endovascular Repair of Thoracic Aortic Aneurysms
Recent Patents on Cardiovascular Drug Discovery The Co-agonist Site of NMDA-glutamate Receptors: A Novel Therapeutic Target for Age-related Cognitive Decline
Current Pharmaceutical Design Treatment and Prevention of Alcohol Hangover
Current Drug Abuse Reviews Anti-Inflammatory Agents in Ageing and Age-Associated Diseases
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Edible Transgenic Plant Vaccines for Different Diseases
Current Pharmaceutical Biotechnology Venom Peptide Modulators of the Immune System
Inflammation & Allergy - Drug Targets (Discontinued) From the Editors Perspective: Inflammatory Glial Cells of the Nervous System: Assistants or Assassins?
Current Neurovascular Research Cognitive Dysfunction in FMR1 Premutation Carriers
Current Psychiatry Reviews Editorial [Hot Topic: Anti-Amyloidogenic/Protein-Misfolding Therapies in Amyloidosis and Other Protein-Misfolding Disorders (Executive Editor: Masahito Yamada)]
Current Pharmaceutical Design Amyloid Deposition and Inflammation in APPswe/PS1dE9 Mouse Model of Alzheimers Disease
Current Alzheimer Research PDE4D Gene in the STRK1 Region on 5q12: Susceptibility Gene for Ischemic Stroke
Current Medicinal Chemistry Editorial [Hot Topic: Modifying Cardiovascular Risk Factors: Epidemiology and Characteristics of Hypertension-Related Disorders (Executive Guest Editor: Aurelio Leone)]
Current Pharmaceutical Design Integrated System Pharmacology and <i>In Silico</i> Analysis Elucidating Neuropharmacological Actions of <i>Withania somnifera</i> in the Treatment of Alzheimer’s Disease
CNS & Neurological Disorders - Drug Targets Hyperphosphorylation of Microtubule-Associated Protein Tau: A Promising Therapeutic Target for Alzheimer Disease
Current Medicinal Chemistry Impact of the Presence of Select Cardiovascular Risk Factors on Cognitive Changes among Dementia Subtypes
Current Alzheimer Research The Interactions Between Alzheimer’s Disease and Major Depression: Role of Ca<sup>2+</sup> Channel Blockers and Ca<sup>2+</sup>/cAMP Signalling
Current Drug Research Reviews Atypical Chest Pain in ACS: A Trap Especially for Women
Current Pharmaceutical Design Origin and Expansion of Trinucleotide Repeats and Neurological Disorders
Current Genomics